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Abstract
The methyl-d3 amide derivative of the polyene antibiotic amphotericin B was synthesized, assayed for biological activity,
incorporated into mechanically aligned bilayers of dipalmitoylphosphatidylcholine (DPPC), and examined by deuterium and
phosphorus NMR. The amide derivative has a lesser, but qualitatively similar, biological activity relative to amphotericin B.
Incorporation of the amide derivative and ergosterol into aligned DPPC bilayers resulted in a single, stable bilayer phase, as
shown by phosphorus NMR of the DPPC headgroups. Deuterium NMR spectra revealed one major 2H quadrupolar
splitting and one major 2H^1H dipolar splitting in the liquid-crystalline phase, consistent with a high degree of alignment and
a single, averaged physical state for amphotericin B methyl-d3 amide in the bilayer. Variations of the quadrupolar and
dipolar splittings as a function of macroscopic sample orientation and temperature indicated that the amide derivative
undergoes fast rotation about a motional axis that is parallel to the bilayer normal. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
With increased use of immunosuppressive thera-
pies as part of organ transplantation and the advent
of immunocompromising diseases such as AIDS,
fungal disease has assumed greater importance in
the clinical management of already compromised pa-
tients. For treatment of systemic fungal infections,
amphotericin B is still considered the gold standard.
Unfortunately, amphotericin B is not a benign drug
and possesses severe side e¡ects. E¡orts to improve
the therapeutic pro¢le of the drug have included
chemical derivatization [1^3] and alterations in the
mode of drug delivery [4,5].
Prevailing models of the mechanism of action of
amphotericin B postulate formation of ion-perme-
able membrane channels as the direct cause of am-
photericin B activity and toxicity [6^8]. These chan-
nels result in selective permeability changes and
subsequent cell death. Evidence that amphotericin
B forms ion channels in membranes is provided by
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functional studies of ion conductance [9^12]. Because
of the sterol dependence of channel formation, the
selectivity of amphotericin B is thought to be due to
a greater binding a⁄nity for ergosterol in fungal
membranes than for cholesterol in mammalian mem-
branes [13,14]. However, this di¡erence in binding
a⁄nity is not great and presumably results in the
narrow range observed clinically between therapeutic
and toxic levels.
Structurally, amphotericin B belongs to a class of
molecules called polyenes which are characterized by
the presence of a large lactone ring containing multi-
ple, conjugated double bonds. An X-ray di¡raction
study of amphotericin has elucidated the overall
structure of amphotericin B [15,16]. Insights into
the structural organization of amphotericin B in
membranes have been provided by various physical
studies. Fluorescence and magnetic resonance studies
have been used to study membrane-bound polyene
antibiotics indirectly, through their e¡ects on appro-
priately labeled sterols, phospholipids, or other mem-
brane probes [17^23]. In contrast, circular dichroism
provides a direct method for monitoring amphoter-
icin B in membranes. Studies based on this technique
indicate the presence of multiple polyene species and
provide information about their relative amounts
[12,24^26]. Another technique, polarized absorption
spectroscopy, has yielded information about ampho-
tericin B orientation in lipid monolayers [27]. In a
study based on electron spin resonance, ESR spectra
showed that a spin-labeled derivative of amphoteri-
cin B in lipid vesicles possessed a high degree of
motion and was not aggregated [28].
The use of solid-state NMR techniques allows am-
photericin B to be studied in a physiologically rele-
vant environment at atomic resolution. However, in-
troducing a stable-isotope label into amphotericin B
by chemical synthesis is di⁄cult [29^31]. Perhaps, a
more cost-e¡ective, initial strategy is to introduce a
stable-isotope label by chemical modi¢cation and to
study the resulting amphotericin B derivative. Such a
derivative can be expected to provide insights into
amphotericin B behavior based on the similarity be-
tween semi-synthetic derivatives and amphotericin B
in their mode of action [32^35].
In this study, a methyl-d3 amide derivative of am-
photericin B was synthesized and incorporated into
mechanically aligned DPPC bilayers. Phosphorus
NMR spectra of the phosphocholine headgroup of
DPPC provided information about the behavior of
the surrounding bilayer while deuterium NMR spec-
tra of the deuterated methyl group allowed the ori-
entation and motion of the derivative to be moni-
tored. The resulting data show that amphotericin B
methyl-d3 amide is uniformly aligned in a membrane
environment and undergoes fast rotation about an
axis that is parallel to the bilayer normal.
2. Materials and methods
2.1. Amphotericin B methyl-d3 amide synthesis
The methyl-d3 amide of amphotericin B was syn-
thesized by the azide method and puri¢ed by coun-
tercurrent distribution according to a general proce-
dure described in the literature [3]. In particular,
138 mg of amphotercin B (E.R. Squibb and Sons,
Princeton, NJ) was reacted with 210 mg of methyl-
d3-amine hydrochloride (98+atom % D, Aldrich,
Milwaukee, WI) in 18.0 ml dimethylformamide using
0.65 ml of diphenylphosphoryl azide and 1.00 ml of
triethylamine. Subsequent countercurrent distribu-
tion was performed with chloroform^methanol^
water in a volume ratio of 2:2:1. Fast-atom bom-
bardment mass spectrometry showed ions consistent
with the molecular weight (940) and primary struc-
ture of the desired product. Thin-layer chromatogra-
phy showed only one spot corresponding to the de-
sired product; no unreacted amphotericin B was
detected.
2.2. Amphotericin B methyl-d3 amide activity
2.2.1. Potassium leakage
Polyene-induced potassium leakage from Candida
albicans and human erythrocytes was measured ac-
cording to a previously described procedure (Kotler-
Brajtburg et al., [32]). Cells of C. albicans B311 used
in the measurements were obtained from our stock
culture collection and maintained on Sabouraud dex-
trose agar slants. Appropriately prepared samples of
fungal cells or erythrocytes were incubated with
varying concentrations of either amphotericin B
methyl-d3 amide or a corresponding amount of am-
photericin B as Fungizone (Bristol-Myers Squibb,
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Princeton, NJ). The results were calculated and ex-
pressed as a percentage of the control samples. From
a graphic plot of the data, the concentration of anti-
biotic required for a 50% e¡ect was calculated.
2.2.2. Minimum inhibitory concentration (MIC)
The MIC was considered to be the lowest concen-
tration of amphotericin B methyl-d3 amide or am-
photericin B (Fungizone) that completely inhibited
growth of C. albicans B311 cells.
2.3. Membrane incorporation
A previously developed protocol for preparation
of aligned bilayers [36] proved su⁄ciently robust
that the same methodology could be used to incor-
porate the polyene derivative into sterol-containing
DPPC bilayers. In this protocol, inclusion of water
in the deposition solvent plays a critical role in the
alignment process. In the present study, amphoteri-
cin B methyl-d3 amide, ergosterol (Sigma), and
DPPC (Avanti) were dissolved in a solution of
94.9% methanol in deuterium-depleted water (Isotec)
before deposition onto glass coverslips and subse-
quent hydration. Based on the weight of materials
used, the NMR sample contained a total of 2.5 mg
of the material produced by derivatization of ampho-
tericin B, and the polyene:sterol:phospholipid molar
ratios were estimated to be V1:2:100.
2.4. NMR data acquisition
2.4.1. NMR instrumentation
NMR data were acquired using a transmission-line
probe tuned to the 1H, 31P, and 2H Larmor frequen-
cies of 300, 121, and 46 MHz, respectively, and a
Chemagnetics/Varian CMX300 spectrometer (Fort
Collins, CO) equipped with PTS 500 and PTS 160
frequency synthesizers (Programmed Test Sources,
Acton, MA). Power ampli¢ers included models
166UP and LP1000 (Kalmus Engineering Interna-
tional, Woodinville, WA) operating at 1H and 31P
Larmor frequencies, respectively; and an LPI-10
model (ENI Power Systems, Rochester, NY) operat-
ing at the 2H Larmor frequency.
2.4.2. 31P-NMR acquisition parameters
All phosphorus spectra were acquired with a sin-
gle, phase-cycled, 30-Ws pulse. A spectral width of
40 kHz was used to collect the 4096 points constitut-
ing each spectrum, resulting in a digital resolution of
9.766 Hz/point. Proton decoupling was applied with
a duty cycle of 0.3%. In each plot, zero ppm repre-
sents the resonance frequency of external 85% phos-
phoric acid.
2.4.3. 2H-NMR acquisition parameters
All deuterium spectra were acquired with a phase-
cycled, composite (form II) quadrupole echo se-
quence [37]. The 90‡ pulse width was 5 Ws, and the
interpulse delay was 30 Ws. A spectral width of
100 kHz was used to collect 16384 points for each
spectrum, yielding a digital resolution of 6.104 Hz/
point. The duty cycle of applied proton decoupling
was 0.8%. In each plot, zero Hz represents the reso-
nance frequency of external 2H2O.
2.4.4. Temperature regulation
Temperature control was provided by an XRII851
Air-Jet Crystal Cooler equipped with a TC-84
temperature controller and an AD-80 air dryer
(FTS Systems, Stone Ridge, NY). A thermocouple
(Omega Engineering, Stamford, CT) was used to
monitor the temperature of the air at the exhaust
port of the probe head. The sample was allowed to
equilibrate at each temperature T for at least 0.5 h
prior to data acquisition. The transition between
sample temperatures was accomplished by changing
T by 10‡C over a period of v 0.5 h (unless otherwise
noted).
2.4.5. Macroscopic sample orientation
The orientation of the sample in the magnetic ¢eld
was quanti¢ed by the angle L between the normal to
the glass coverslips and the direction of the magnetic
¢eld. Data were acquired at two di¡erent macro-
scopic sample orientations: L= 0‡ and L= 90‡.
2.4.6. Sample stability
All NMR signals were stable over the time per-
iods required to acquire spectra. Furthermore, prep-
aration of similar, aligned bilayer samples from dif-
ferent synthetic batches of amphotericin B methyl-d3
amide con¢rmed the reproducibility of the acquired
data.
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3. Results
3.1. Chemical structure of amphotericin B methyl-d3
amide
Fig. 1 shows the chemical structure of amphoter-
icin B methyl-d3 amide. The amide bond between
C-41 and the amide nitrogen is assumed to form
with the methyl-d3 group trans to the macrolide
ring so that the two bulkiest substitutents are fur-
thest from each other. Moreover, because crystal
structures of typical methyl amide compounds show
their coordinates to be in good agreement with those
of the trans peptide bond [38], the backbone atoms in
the methyl-d3 amide group of the derivative can be
viewed as forming a peptide plane.
The mycosamine sugar moiety and the macrolide
lactone ring of the parent amphotericin B compound
remain unaltered. In particular, the macrolide ring
retains the rigidity conferred by the ketal ring and
the fully extended, trans-con¢gured, conjugated dou-
ble bonds [16]. A quantitative representation of the
entire amphotericin B methyl-d3 amide molecule is
obtained by constructing a methyl-d3 amide plane
based on the coordinates of a peptide plane [39]
and then grafting the methyl-d3 amide plane onto
the X-ray coordinates that represent amphotericin
B [16]. A single, direct bond denoted by C-16^C-41
connects the methyl-d3 amide group to the rest of theFig. 1. Chemical structure of amphotericin B methyl-d3 amide.
Fig. 2. 2H-NMR spectra of the powder form of: (a) 100 mg of
L-[3,3,3-d3]alanine acquired at T = 4‡C with tR = 1.0 s and 3072
scans; (b) 100 mg of methyl-d3-amine hydrochloride acquired
at T =339‡C with tR = 16.0 s and 2560 scans; and (c) 7 mg of
amphotericin B methyl-d3 amide acquired at T =340‡C with
tR = 16.0 s and 81904 scans. The spectra were acquired without
1H decoupling and are plotted with 500 Hz of line broadening.
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amphotericin B derivative (Fig. 1). The molecule pos-
sesses a degree of freedom arising from rotation
about the C-16^C-41 bond axis. However, rotation
about this axis has only a minor e¡ect in decoupling
the methyl-d3 quadrupolar splitting from the overall
behavior of the entire molecule because the C-16^C-
41 bond and the Namide-C-48 bond are roughly par-
allel, di¡ering in orientation by only 9‡.
3.2. Activity of amphotericin B methyl-d3 amide
For induction of 50% leakage of potassium from
C. albicans B311, the required concentration of pow-
der containing amphotericin B methyl-d3 amide was
approximately 1^3 times greater than that of ampho-
tericin B as Fungizone. On the other hand, for in-
duction of 50% leakage of potassium from human
erythrocytes, the required concentration of deriva-
tive-containing powder was approximately 5^6 times
greater than that of amphotericin B. In addition, the
MIC of product containing amphotericin B methyl-
d3 amide was measured to be 3.125 Wg/ml while that
of amphotericin B as Fungizone was 0.391 Wg/ml.
These data show that the biological activity of the
methyl-d3 amide derivative relative to amphotericin
B is consistent with the activities exhibited by other
amide derivatives of amphotericin B [3,40^42]. Most
importantly, these results provide an indication that
amphotericin B methyl-d3 amide functions in a qual-
itatively similar manner to amphotericin B, but is
about 8-fold less potent.
3.3. Powder form of amphotericin B methyl-d3 amide
Deuterium NMR spectra of two common refer-
ence compounds and amphotericin B methyl-d3 in
Fig. 3. 31P-NMR spectra of DPPC bilayers containing amphotericin B methyl-d3 amide and ergosterol acquired at temperatures
T = 61‡C (a,d), 51‡C (b,e), and 41‡C (c,f), and sample orientations L= 0‡ (a-c) and L= 90‡ (d^f). The full-width at half-maximum in-
tensity of individual peaks is 2^3 ppm. Spectra were acquired with tR = 8.0 s, 292 scans, and 10-kHz 1H decoupling, and are plotted
with 30 Hz of line broadening.
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powder form are shown in Fig. 2. The spectra rep-
resent typical Pake patterns generated by randomly
oriented, quadrupolar interactions. Due to methyl
rotational averaging of the C^D EFG about the C3
symmetry axis, the e¡ective EFG tensor is axially
symmetric with the unique principal axis along the
C3 symmetry axis. The symmetry axis is the CK^CL
bond in L-[3,3,3-d3]alanine (Fig. 2a), the N^C bond
in methyl-d3-amine hydrochloride (Fig. 2b), and the
Namide^C-48 bond in amphotericin B methyl-d3
amide (Fig. 2c). The peak-to-peak splittings mea-
sured at half-maximum intensity without added line
broadening are 41.3 kHz (Fig. 2a), 37.5 kHz (Fig.
2b), and 39.7 kHz (Fig. 2c). The widths of the
peak-to-peak splittings correspond to the quantity
M(1/4)(e2qQ/h)M for typical methyl-d3 rotation, where
e2qQ/h is the static quadrupolar coupling constant.
3.4. Liquid-crystalline phase of the bilayer sample
3.4.1. DPPC
Phosphorus NMR spectra of the phospholipid/
sterol/polyene sample in the liquid-crystalline phase
are shown in Fig. 3. The single peak in each spec-
trum arises from the phospholipid headgroups and
re£ects the presence of a single lipid phase. The nar-
row line width of each peak proves that all DPPC
Table 1
31P-NMR chemical shift anisotropy of aligned DPPC bilayers
containing amphotericin B methyl-d3 amide and ergosterol as a
function of temperature and sample orientation
T (‡C) XCSA (ppm)
L= 0‡ L= 90‡
61 28.0 314.5
51 28.3 315.1
41 28.8 315.0
Fig. 4. 2H-NMR spectra of amphotericin B methyl-d3 amide in ergosterol-containing DPPC bilayers acquired at temperatures
T = 61‡C (a,d), 51‡C (b,e), and 41‡C (c,f), and sample orientations L= 0‡ (a^c) and L= 90‡ (d^f). No peaks are present outside the
plotted frequency range. Spectra were acquired with tR = 0.5 s, 49152 scans, and no 1H decoupling, and are plotted with 10 Hz of line
broadening.
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molecules have the same orientation. The chemical
shift (XCSA) measured at L= 0‡ is nearly twice that at
L= 90‡ (Fig. 3, Table 1), which indicates that DPPC
headgroups rotate rapidly about a motional axis
which is parallel to the coverslip normal [43]. This
axis is also parallel to the bilayer normal because the
coverslip and bilayer normals coincide in the liquid-
crystalline phase. Identi¢cation of the long axis of
the phospholipid as the motional axis is an arrange-
ment that is consistent with the known structure of
DPPC in liquid-crystalline bilayers [44,45].
The spectra in Fig. 3c and f were obtained at the
nominal phase transition temperature of pure DPPC,
T = 41‡C. These spectra show that the majority of the
sample remains liquid-crystalline. However, the
broadening at the base of the peaks and concomitant
decrease in peak heights reveal the presence of some
gel-phase lipid and so indicate the onset of the phase
transition.
3.4.2. Amphotericin B methyl-d3 amide
Deuterium NMR spectra of the phospholipid/ster-
ol/polyene sample in the liquid-crystalline phase have
well-de¢ned splittings and narrow line widths (Fig.
4), indicating a high degree of alignment. Each spec-
trum in Fig. 4 shows a major splitting of a few kHz
with superimposed minor splittings of a few hundred
Hz. The major splitting is the quadrupolar splitting
of the methyl deuterons. The minor splittings disap-
pear with proton decoupling (Fig. 5), and therefore
are assigned to the dipolar interaction between the
methyl deuterons and the adjacent single proton.
The presence of only a single quadrupolar splitting
(vXQ) and a single dipolar splitting (vXD) shows that
the methyl-d3 amide group of the derivative adopts a
single, average orientation in the lipid matrix. These
splittings depend on the macroscopic sample orienta-
tion L (Fig. 4, Table 2). For the quadrupolar split-
ting, the equation describing rapid rotation of the
Fig. 5. Proton-decoupled 2H-NMR spectra of amphotericin B methyl-d3 amide in ergosterol-containing DPPC bilayers acquired at
temperatures T = 61‡C (a,d), 51‡C (b,e), and 41‡C (c,f), and sample orientations L= 0‡ (a^c) and L= 90‡ (d^f). The full-width at half-
maximum intensity of individual peaks is on the order of 100^200 Hz. Spectra were acquired with tR = 0.5 s, 49152 scans, and 3-kHz
1H decoupling, and are plotted with 10 Hz of line broadening.
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e¡ective EFG tensor about a motional axis [46] be-
comes for a typical methyl rotor,
v XQ  31=2e2qQ=hG3 cos2 a ÿ 1=2f
U3 cos2 L 0 ÿ 1=2 1
The symbol a represents the angle between the
Namide^C-48 bond and the motional axis; LP is the
angle between the motional axis and the direction of
the magnetic ¢eld; and G f denotes a time average
over motions occurring during the time scale of the
NMR measurement. The quadrupolar splittings
measured at L= 0‡ are twice those measured at
L= 90‡ (Table 2), which, according to Eq. (1), means
that the quadrupolar tensor must rotate rapidly
about a motional axis which is parallel to the cover-
slip (bilayer) normal so that LP=L. A similar analysis
of the dipolar splittings yields the same conclusion.
(Because of the rigid geometry of the backbone
atoms of the methyl-d3 amide group, the quadrupo-
lar and dipolar splittings provide information about
the same structural unit.)
The values of the splittings MvXQM and MvXDM de-
crease as the temperature decreases (Figs. 4 and 5),
with the change in MvXDM much less than the change
in MvXQM. These trends are inconsistent with temper-
ature-dependent motional averaging but can be at-
tributed to slight changes in the bilayer orientation
of the methyl-d3 amide group with temperature.
Such a change for the methyl-d3 amide group will
alter the orientations of quadrupolar and dipolar
tensors di¡erently with respect to the static ¢eld
and hence result in di¡erent temperature trends for
dvXQd and dvXDd. The integrated spectral intensity of
the major peaks remains unchanged as a function of
temperature, so the number of amphotericin B meth-
yl-d3 amide molecules contributing signal intensity to
the major peaks remains constant.
4. Discussion
4.1. Phospholipid phase behavior
The phosphorus NMR results show that the phys-
ical behavior of DPPC in the phospholipid/sterol/
polyene sample is generally the same as that of
pure DPPC. In the liquid-crystalline and gel phase
of this sample, DPPC behaves similarly to pure
DPPC exhibiting axial rotation in a single phase
[47]. The measured 31P chemical shift anisotropies
(Table 1) are also in good agreement with previous
measurements of pure DPPC [47^50]. Thus, the con-
centration of ergosterol (or amphotericin B methyl-
d3 amide) in the sample does not appear to be su⁄-
cient to alter signi¢cantly DPPC headgroup behav-
ior. Interpreting the observed phosphorus line shapes
in terms of the axial rotation and lateral di¡usion of
a pure phospholipid is therefore appropriate [51].
The e¡ect of ergosterol (and polyene) on the gel/
liquid-crystalline phase transition is minimal. The
onset of minor line broadening in the 31P-NMR
spectra acquired at T = 41‡C (Fig. 3c,f) is consistent
with a phase transition temperature that is not sig-
ni¢cantly altered from that of pure DPPC. Given the
small amount of ergosterol present in the sample
(1:50, ergosterol :DPPC), such a result should prob-
ably be expected, especially since an analogous ster-
ol, cholesterol, at a similar concentration does not
greatly perturb the thermotropic phase behavior of
DPPC [52,53].
4.2. Structural characteristics of amphotericin B
methyl-d3 amide, and motion and alignment in the
bilayer
Analysis of the deuterium NMR data is greatly
facilitated by the structure of amphotericin B meth-
Table 2
2H-NMR quadrupolar splittings and 2H^1H dipolar splittings
of amphotericin B methyl-d3 amide in ergosterol-containing,
aligned DPPC bilayers as a function of temperature and sample
orientation
T (‡C) MvXQM (Hz) MvXDMa (Hz)
L= 0‡ L= 90‡ L= 0‡ L= 90‡b
61 2000 1000 200 90
51 1240 620 180 80
41 560 240 160 70c
aThe statistical signi¢cance of the slight di¡erences between val-
ues of MvXDM measured at di¡erent temperatures has not been
determined.
bThese values are estimates based on an analysis of spectral
line shape.
cThis value was con¢rmed by direct measurement of MvXDM
from a higher-quality spectrum obtained under identical condi-
tions.
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yl-d3 amide, whose relatively rigid macrolide ring
and methyl-d3 amide plane limit the degrees of con-
formational freedom. Furthermore, because the
methyl-d3 amide group is connected by a single, di-
rect bond (C-16^C-41) to the rest of the amphoter-
icin B derivative, the conclusion that the methyl-d3
amide group rotates rapidly about an axis parallel to
the bilayer normal strongly suggests that the entire
polyene molecule undergoes the same motion.
The highly uniform alignment of amphotericin B
methyl-d3 amide molecules achieved in the liquid-
crystalline phase demonstrates the sensitivity of the
polyene to the orienting e¡ects of the lipid matrix.
The small, resolvable dipolar splittings in the deute-
rium NMR spectra (dipolar splittings as small as 70
Hz are resolved in some cases) would undoubtedly
have been obscured under alignments that are only
slightly less uniform.
Because amphotericin B methyl-d3 amide has bio-
logical activity qualitatively similar to that of am-
photericin B, we believe that what we learn about
the amide derivative in bilayers is relevant to the
behavior of amphotericin B itself. Experiments with
the amide derivative are in progress to probe the
polyene concentration dependence of bilayer orienta-
tion, aggregation, and channel formation.
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